drugset / Trial / NCT00424697

A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.

NCT00424697

Phase 1 Completed 26 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindDiagnostic

Summary

Data suggests that imaging activity of the brain can measure the effects of anti-anxiety drugs. This study will investigate the effect of GW876008 on areas of the brain involved with thinking and emotion

Timeline

Start
2007-03
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule
Subject Lorazepam Small molecule

Indications

No indication recorded.